Pembrolizumab Combined With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Oesophageal Squamous Cell Carcinoma: Protocol for a Multicentre, Prospective, Randomized-Controlled, Phase III Clinical Study (Keystone-002)

BACKGROUND: To compare the efficacy and safety of pembrolizumab combined with neoadjuvant chemotherapy (neoCT) versus neoadjuvant chemoradiotherapy (neoCRT) followed by surgery for locally advanced resectable oesophageal squamous cell carcinoma (ESCC). METHODS: This study is a multicentre, prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Xiaobin, Zhang, Wencheng, Zhao, Gang, Liang, Fei, Zhang, Chen, Yue, Jie, Duan, Xiaofeng, Ma, Zhao, Chen, Chuangui, Pang, Qingsong, Zhang, Weihong, Liu, Liang, Ren, Xiubao, Meng, Bin, Zhang, Peng, Ma, Yegang, Zhang, Lin, Li, Hecheng, Kang, Xiaozheng, Li, Yin, Jiang, Hongjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008846/
https://www.ncbi.nlm.nih.gov/pubmed/35433421
http://dx.doi.org/10.3389/fonc.2022.831345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008846/
https://www.ncbi.nlm.nih.gov/pubmed/35433421
http://dx.doi.org/10.3389/fonc.2022.831345

Ejemplares similares